Wednesday 7th February 2024 |
Text too small? |
TruScreen receives Approval in Mexico to enter public health sector
Highlights
• TruScreen received Cofepris approval in Mexico, a major milestone and endorsement of the TruScreen technology
• Cofepris is Mexico’s national regulator and the approval grants TruScreen access to the country’s public health sector.
Truscreen Group Limited (NZX/ASX:TRU) is pleased to announce that the national regulator of Mexico, Cofepris has approved TruScreen access to the public health sector.
The approval allows TruScreen to expand its cervical cancer screening, currently, in the private health clinics to the wider public health sector. A 2020 census identified that only 2.3% of the population have private healthcare while 70.9% of the population accessed the public health system. Mexico has an addressable market of 65 million women.
HPVcentre.net estimated that 9,400 women are diagnosed annually with cervical cancer with a mortality rate of 46% - 4,300 deaths. Cervical cancer is the second most prevalent cancer amongst women in Mexico.
The CEO, Dr Beata Edling commented:
“The Cofepris approval highlights the accelerating acceptance of the TruScreen technology globally. I am delighted that women in Mexico will have access to faster, more efficient, and reliable cervical cancer screening with TruScreen. We congratulate our partner, Sunbird on achieving this significant milestone and look forward to advancing cervical cancer screening in Mexico”.
This announcement has been approved by the Board.
Ends
No comments yet
EXPRESSION OF INTEREST IN THE SUPPLY OF MEREENIE GAS
IPL - FY24 Annual Results
CEN - Contact to revisit Wairākei development options
May 17th Morning Report
PaySauce to announce full year results on 22 May 2024
BGP - Results of Briscoe Group Limited Annual Shareholder Meeting
Judith Swales to leave Fonterra
Fonterra announces step-change in strategic direction
USX Trading Results 15th May
Devon Funds Morning Note - 15 May 2024